Experts

Taylor Hansen is an innovative brand and growth leader with 20 years of proven experiencebuilding and scaling iconic global and emerging brands. She has led businesses across multipleverticals within LVMH, VF Corporation, and Zadig&Voltaire, and most recently scaling heraward-winning consultancy, The Versed Group.Blending creativity with commercial strategy, she drives growth that moves culture. At LVMH,she concepted and led the build and commercial implementation of the world’s first AI-poweredskincare and color face finder—now a standard for leading wellness brands and responsible forbillions in conversion revenue.A Sustainable MBA graduate and certified Integrative Health Practitioner, Taylor is deeplycommitted to advancing women’s health innovation and Lyme disease awareness.As Chief Marketing & Commercial Officer at Xella Health, Taylor joins the team in redefining thefuture of women’s healthcare. A speaker, mentor, and Forbes contributor, she is known foruniting brands and teams around purposes that are both socially responsible and commerciallypowerful.

Rohit is a technology leader and marketplace innovation expert with a background in computer science from Arizona State University. He previously ran a software agency in California and has collaborated with global brands through agencies like TBWA on projects for Nike, Apple, and McDonald’s.At Jeweler Collective, he leads product and platform development—ensuring that technology serves cultural storytelling and commerce. Rohit is available to comment on marketplace infrastructure, inclusive innovation, and scaling cultural brands through tech.

A former venture capitalist with a passion for scaling consumer brands, Patricia has been an operator and investor in beauty for over two decades. Her passion lies in helping brand founders and creators build iconic brands that combine product innovation and market white-space with genuine storytelling.Patricia has extensive experience working with, scaling, and financing celebrity / creator / influencer brands. As a female entrepreneur and founder, she is fanatical about championing other women in business.Patricia holds a BA from Harvard College magna cum laude and an MBA from Harvard Business School. She has been named one of the 100 Most Powerful Women by Entrepreneur Magazine and been featured in the New York Times, WWD and Glossy for her impact in beauty space.

Kelly Lacob is a healthcare technologist, product designer, and systems thinker redefining howwe deliver care—making it more preventive, personalized, and accessible. Trained at Stanfordand Johns Hopkins in human biology, bioengineering, and business, Kelly has built her careertranslating early-stage science into scalable products that change lives for traditionallyunderserved patient populations.Before co-founding Xella Health, Kelly led the product design and roadmap for the firstCRISPR-powered diagnostic platform at Mammoth Biosciences, and the development andlaunch of the first FDA-cleared point-of-care and at-home PCR test at Visby Medical—adiagnostic breakthrough that helped power early COVID-19 response efforts. Her portfolio ofpast products spans more than a dozen healthcare innovations, including a remote-monitoringplatform for hypertension, diabetes, and preeclampsia, a surgical-supply bundling solution thatreduced postoperative infection, a community-based hearing-screening platform enablingtask-shifting to lower-level health workers, and a smart wound sensor and mobile app to preventpressure sores.Now as Co-Founder and CEO of Xella Health, Kelly is applying her expertise in product designand commercialization to bridge the gap between cutting-edge research and everyday clinicalcare for women and their families.

Jesus Ching is a scientist, inventor, and entrepreneur with over 30 years of experience andmore than 50 patents spanning molecular diagnostics, genomics, proteomics, andCRISPR-based technologies. A true pioneer in next-generation diagnostics, Jesus has built acareer transforming scientific innovation into clinically impactful, commercially successfulproducts.He has founded multiple diagnostics companies, three of which were acquired by industryleaders Bio-Rad, Luminex/DiaSorin, and Cepheid/Danaher. His deep technicalexpertise—combined with a relentless focus on first-principles thinking—has led to the creationand launch of numerous products across point-of-care, lab-based, and multi-omic testingplatforms that redefine what’s possible in human diagnostics.At Xella Health, Jesus leads the company’s scientific and technological vision, applying hisdecades of experience in molecular systems design to power Xella’s AI- and multi-omic-basedprecision health platform for women. Jesus holds a PhD in Chemistry from Baylor University anda BS in Biology and Chemistry from Houston Baptist University.

James (Jim) Parchem is an accomplished finance and operations leader with extensive experience across retail, health, wellness, and consumer goods. Currently serving as CFO at Itzy Ritzy, Jim partners with private equity to drive growth and value creation through strategic leadership in carve-outs, acquisitions, divestitures and capital strategies.He brings deep expertise in asset-based lending, working capital optimization, interest rate derivatives, S&OP processes and automation initiatives, along with a strong background in budgeting, pricing strategy and advanced financial modeling. Jim is recognized for his ability to balance strategic vision with operational excellence, consistently delivering measurable impact on profitability and efficiency.He holds an MBA in Finance, Entrepreneurship, Operations and General Management from the University of Chicago Booth School of Business, and is known for his integrity, growth-minded leadership and ability to build high-performing teams.

Adriana Dantas is a global biotech and medical-device leader with more than 20 years ofexperience bringing breakthrough technologies from bench to bedside. A biochemist andpharmacist turned business strategist, she has built a career at the intersection of science,operations, and commercialization—bridging research innovation with real-world impact.Before co-founding Xella Health, Adriana held senior executive roles at Roche, BectonDickinson, and Mammoth Biosciences, where she led cross-functional teams spanning R&D,operations, and go-to-market execution. Her leadership has guided product portfolios thatachieved first- and second-in-market share positions globally, and she has lived and led acrossfive countries, cultivating a truly international perspective on healthcare delivery and innovation.One of her proudest achievements was leading the women's health division at Roche, includingthe acquisition and multinational rollout of the Ariosa line for non-invasive prenatal testing.She holds an MBA from FGV (Brazil) and Cranfield School of Management (UK), and aDoctorate in Pharmacy and Biochemistry from the University of São Paulo.